ALCOHOL, NUTRITION, AND IMMUNOMODULATION
酒精、营养和免疫调节
基本信息
- 批准号:2882035
- 负责人:
- 金额:$ 29.44万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1996
- 资助国家:美国
- 起止时间:1996-03-01 至 2001-02-28
- 项目状态:已结题
- 来源:
- 关键词:AIDS HIV infections Kupffer's cell S adenosylmethionine alcoholic hepatitis alcoholic liver cirrhosis antioxidants cellular pathology clinical research disease /disorder model ethanol free radical oxygen glutathione human subject human therapy evaluation interleukin 8 laboratory mouse laboratory rat liver disorder chemotherapy mitochondria nuclear factor kappa beta oxidative stress superoxide dismutase tocopherols tumor necrosis factor alpha
项目摘要
Tumor necrosis factor (TNF) is a macrophage/monocyte-derived inflammatory
cytokine whose dysregulation has been shown by us and others to play an
important role in the pathophysiology of several forms of liver injury
including that observed in alcoholic liver disease (ALD). TNF also has
been postulated to play a pivotal role in the metabolic complications and
wasting of Acquired Immunodeficiency Syndrome (AIDS). There are great
similarities between the metabolic abnormalities/complications of AIDS and
ALD including anorexia, cachexia, immune suppression, hypoalbuminemia,
increased acute phase reactants and edema, to name only a few. We have
demonstrated increased plasma TNF, increased monocyte TNF production, and
increased hepatic immunohistochemical staining for TNF in patients with
ALD. Mitochondrial dysfunction/structural damage is an early event in
ALD, and it has also been postulated to play a role in organ dysfunction
in AIDS. TNF, per se, causes mitochondrial dysfunction/damage including
inhibition of respiration, superoxide generation, and ultimately cell
injury. Impairment of normal mitochondrial respiration markedly enhances
TNF cytotoxicity. TNF mediated cytotoxicity is thought to be an oxidant
injury, and TNF induction of the mitochondrial antioxidant manganous
superoxide dismutase (MnSOD) is an endogenous protective mechanism to
prevent ongoing TNF cytotoxicity. Regulation of cytokines such as TNF has
become a focal point for therapeutic intervention in many diseases
including ALD and AIDS. NFkappaB is a transcription factor for several
cytokines including TNF and for the HIV virus. NFkappaB is activated by
reactive oxygen intermediates, and this activation can be blocked by
antioxidants such as vitamin E (Vit E) and glutathione (GSH)-enhancing
agents in certain transformed cell lines. It is our working hypothesis
that TNF plays an etiologic role in many of the clinical/biochemical
abnormalities observed in ALD and AIDS. We postulate that chronic alcohol
abuse and HIV infection cause increased gut permeability and endotoxemia,
depletion of many nutrient antioxidants (e.g., GSH, Vit E), generation of
reactive oxygen intermediates, activation of NFkappaB, increased TNF
production, mitochondrial dysfunction with mitochondrial GSH depletion,
and ultimately wasting and organ dysfunction including liver injury. The
overall research goals of this laboratory are to further define mechanisms
and modulatory pathways whereby cytokines, such as TNF, induce metabolic
disturbances/liver injury in ALD and in AIDS, with the ultimate goal being
development of specific "anticytokine" therapy for ALD and for AIDS. The
specific objectives in this proposal (initially performed in ALD patients)
are to: 1) Evaluate dysregulated cytokine (TNF, IL-8) production in ALD,
the role of antioxidant status and NFkappaB activation in modulating this
cytokine production and the role of "anticytokine" therapy; 2) Determine
the role of mitochondrial dysfunction/protection in alcohol/TNF-mediated
hepatotoxicity; and 3) Determine whether unique forms of antioxidant
therapy attenuate dysregulated TNF production and mitochondrial
dysfunction in patients with ALD. This research spans the spectrum from
molecular cellular studies to applied human investigations, with the
ultimate goal being improved knowledge and therapy for these two
devastating disease processes with overlapping metabolic complications.
肿瘤坏死因子(TNF)是一种巨噬细胞/单核细胞衍生的炎症因子,
我们和其他人已经证明,这种细胞因子的失调,
在几种形式的肝损伤的病理生理学中的重要作用
包括在酒精性肝病(ALD)中观察到的。 TNF也有
被认为在代谢并发症中起着关键作用,
获得性免疫缺陷综合征(艾滋病)。 存在很大
艾滋病的代谢异常/并发症与
ALD包括厌食、恶病质、免疫抑制、低白蛋白血症,
增加急性期反应物和水肿,仅举几例。 我们有
显示血浆TNF增加,单核细胞TNF产生增加,
肝肿瘤患者的TNF免疫组化染色增加
ALD。 线粒体功能障碍/结构损伤是一个早期事件,
ALD,它也被假定在器官功能障碍中发挥作用
艾滋病 TNF本身引起线粒体功能障碍/损伤,包括
抑制呼吸、超氧化物生成,并最终抑制细胞
损伤 正常线粒体呼吸的损伤显著增强了
TNF细胞毒性。 TNF介导的细胞毒性被认为是一种氧化剂
损伤和TNF诱导的线粒体抗氧化剂锰
超氧化物歧化酶(MnSOD)是一种内源性保护机制,
防止持续的TNF细胞毒性。 细胞因子如TNF的调节
成为许多疾病治疗干预的焦点
包括ALD和艾滋病。 NF κ B是一种转录因子,
细胞因子包括TNF和HIV病毒。 NF κ B被激活,
活性氧中间体,这种激活可以被阻断,
抗氧化剂,如维生素E(Vit E)和谷胱甘肽(GSH)-增强
某些转化细胞系中的药物。 我们的假设是
TNF在许多临床/生化疾病中起着病因学作用,
在ALD和艾滋病中观察到的异常。 我们假设长期酗酒
滥用和HIV感染导致肠道通透性增加和内毒素血症,
许多营养抗氧化剂的耗尽(例如,GSH、维生素E),产生
活性氧中间体,NF κ B活化,TNF增加
产生,线粒体功能障碍伴线粒体GSH耗竭,
并最终导致消耗和器官功能障碍,包括肝损伤。 的
该实验室的总体研究目标是进一步确定机制
以及细胞因子如TNF诱导代谢的调节途径
ALD和AIDS中的干扰/肝损伤,最终目标是
开发针对ALD和AIDS的特异性“抗细胞因子”疗法。 的
本提案的具体目标(最初在ALD患者中进行)
1)评估ALD中失调的细胞因子(TNF,IL-8)产生,
抗氧化状态和NFkappaB激活在调节中的作用
细胞因子的产生和“抗细胞因子”治疗的作用; 2)确定
线粒体功能障碍/保护在酒精/TNF介导
肝毒性;和3)确定是否独特形式的抗氧化剂
治疗减弱失调的TNF产生和线粒体
ALD患者的功能障碍。 这项研究涵盖了从
从分子细胞研究到应用人类研究,
最终目标是改善这两个人的知识和治疗
破坏性的疾病过程与重叠的代谢并发症。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CRAIG J. MCCLAIN其他文献
CRAIG J. MCCLAIN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CRAIG J. MCCLAIN', 18)}}的其他基金
Inflammation Resolving Lipid Mediators: Novel Therapy for Alcohol AssociatedLiver Disease
消炎脂质介质:酒精相关性肝病的新疗法
- 批准号:
10590047 - 财政年份:2023
- 资助金额:
$ 29.44万 - 项目类别:
Administrative Supplement to Hepatobiology and Toxicology COBRE
肝生物学和毒理学 COBRE 行政增刊
- 批准号:
10399887 - 财政年份:2021
- 资助金额:
$ 29.44万 - 项目类别:
Alcoholic Hepatitis Network 3/9 University of Louisville
酒精性肝炎网络 3/9 路易斯维尔大学
- 批准号:
9752421 - 财政年份:2018
- 资助金额:
$ 29.44万 - 项目类别:
Alcoholic Hepatitis Network 3/9 University of Louisville
酒精性肝炎网络 3/9 路易斯维尔大学
- 批准号:
10434741 - 财政年份:2018
- 资助金额:
$ 29.44万 - 项目类别:
Alcoholic Hepatitis Network 3/9 University of Louisville
酒精性肝炎网络 3/9 路易斯维尔大学
- 批准号:
10202391 - 财政年份:2018
- 资助金额:
$ 29.44万 - 项目类别:
相似海外基金
A targeted combination intervention approach for acute HIV infections to curb the explosive epidemic among high-risk populations in Indonesia
针对急性艾滋病毒感染的针对性组合干预方法,遏制印度尼西亚高危人群的爆发性流行
- 批准号:
MR/V035304/1 - 财政年份:2022
- 资助金额:
$ 29.44万 - 项目类别:
Research Grant
IMPAACT RELATED PROTOCOLS FOR THE RESEARCH ON TREATMENT, PREVENTION, DIAGNOSIS AND EPIDEMIOLOGY OF HIV INFECTIONS
HIV 感染的治疗、预防、诊断和流行病学研究的影响相关方案
- 批准号:
10369859 - 财政年份:2021
- 资助金额:
$ 29.44万 - 项目类别:
Determining the mechanisms of vascular CD8 T cell activation in CMV and HIV infections
确定 CMV 和 HIV 感染中血管 CD8 T 细胞激活的机制
- 批准号:
10461964 - 财政年份:2021
- 资助金额:
$ 29.44万 - 项目类别:
Determining the mechanisms of vascular CD8 T cell activation in CMV and HIV infections
确定 CMV 和 HIV 感染中血管 CD8 T 细胞激活的机制
- 批准号:
10326617 - 财政年份:2021
- 资助金额:
$ 29.44万 - 项目类别:
Combination HIV Prevention: Using anti-retroviral and anti-inflammatory medications to prevent new HIV infections
HIV 联合预防:使用抗逆转录病毒和抗炎药物预防新的 HIV 感染
- 批准号:
404211 - 财政年份:2018
- 资助金额:
$ 29.44万 - 项目类别:
Operating Grants
BALTIMORE: PROJECTS TO REDUCE HIV INFECTIONS AND IMPROVE ENGAGEMENT IN HIV MEDICAL CARE AMONG MSM
巴尔的摩:减少艾滋病毒感染和提高男男性行为者参与艾滋病毒医疗护理的项目
- 批准号:
9078083 - 财政年份:2015
- 资助金额:
$ 29.44万 - 项目类别:
Health Department Demonstration Projects to Reduce HIV Infections and Improve Engagement in HIV Medical Care among Men Who Have Sex with Men (MSM) and Transgender Persons
卫生部示范项目旨在减少男男性行为者 (MSM) 和跨性别者的艾滋病毒感染并提高他们对艾滋病毒医疗护理的参与度
- 批准号:
9079323 - 财政年份:2015
- 资助金额:
$ 29.44万 - 项目类别:
REDUCING HIV INFECTIONS AND IMPROVING ENGAGEMENT IN HIV MEDICAL CARE AMONG MSM IN MEMPHIS TN
减少田纳西州孟菲斯市 MSM 的 HIV 感染并提高其对 HIV 医疗护理的参与度
- 批准号:
9079336 - 财政年份:2015
- 资助金额:
$ 29.44万 - 项目类别:
Double-Negative T cells in SIV and HIV Infections
SIV 和 HIV 感染中的双阴性 T 细胞
- 批准号:
8472130 - 财政年份:2012
- 资助金额:
$ 29.44万 - 项目类别:
REDUCING HIV INFECTIONS AMONG COMMERCIAL SEX WORKERS IN GERT SIBANDE DISTRICT TAV
减少格特西班德区 TAV 商业性工作者的艾滋病毒感染
- 批准号:
8532661 - 财政年份:2011
- 资助金额:
$ 29.44万 - 项目类别: